IRIS UniCatt

Racioppi, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 17.186
NA - Nord America 4.702
AS - Asia 1.960
SA - Sud America 353
AF - Africa 58
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 10
Totale 24.282
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 11.757
US - Stati Uniti d'America 4.601
DE - Germania 1.797
SE - Svezia 880
CN - Cina 661
SG - Singapore 647
NL - Olanda 630
FR - Francia 540
UA - Ucraina 473
BR - Brasile 315
GB - Regno Unito 261
IN - India 215
IE - Irlanda 213
ID - Indonesia 137
RU - Federazione Russa 114
PL - Polonia 111
FI - Finlandia 108
CH - Svizzera 81
CA - Canada 73
JP - Giappone 62
BE - Belgio 49
TR - Turchia 46
ES - Italia 38
HK - Hong Kong 28
KR - Corea 28
CI - Costa d'Avorio 22
VN - Vietnam 20
AT - Austria 19
MX - Messico 18
RO - Romania 18
MA - Marocco 16
AL - Albania 15
IR - Iran 15
AR - Argentina 12
AZ - Azerbaigian 12
GR - Grecia 11
IL - Israele 10
AU - Australia 9
CZ - Repubblica Ceca 9
IQ - Iraq 9
PK - Pakistan 9
AE - Emirati Arabi Uniti 8
TW - Taiwan 8
EC - Ecuador 7
LT - Lituania 7
CO - Colombia 6
EU - Europa 6
KG - Kirghizistan 6
LK - Sri Lanka 6
PT - Portogallo 6
TH - Thailandia 6
PE - Perù 5
SM - San Marino 5
UZ - Uzbekistan 5
ZA - Sudafrica 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BD - Bangladesh 4
BG - Bulgaria 4
EG - Egitto 4
HU - Ungheria 4
IS - Islanda 4
LV - Lettonia 4
MY - Malesia 4
NZ - Nuova Zelanda 4
RS - Serbia 4
BY - Bielorussia 3
CL - Cile 3
HR - Croazia 3
PA - Panama 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
BO - Bolivia 2
BZ - Belize 2
CR - Costa Rica 2
CV - Capo Verde 2
DK - Danimarca 2
DZ - Algeria 2
HN - Honduras 2
LU - Lussemburgo 2
MD - Moldavia 2
MT - Malta 2
NP - Nepal 2
SI - Slovenia 2
TJ - Tagikistan 2
UG - Uganda 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CM - Camerun 1
EE - Estonia 1
GE - Georgia 1
GY - Guiana 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
ME - Montenegro 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PY - Paraguay 1
Totale 24.278
Salva come PNG Salva come JPEG
Città #
Milan 1.212
Rome 1.062
Chandler 987
Ashburn 417
Singapore 395
Naples 344
Jacksonville 263
Turin 221
Florence 216
Dublin 205
San Mateo 205
Bologna 174
Ann Arbor 169
Nanjing 147
Palermo 142
Wilmington 138
Jakarta 132
Bari 122
Los Angeles 117
Catania 105
Genoa 104
Dearborn 90
Verona 90
Bremen 85
New York 85
Nürnberg 85
Kraków 82
Munich 78
Nanchang 75
Woodbridge 75
Lawrence 71
Moscow 68
Boston 66
Brescia 65
Redwood City 63
Marseille 62
Padova 58
Houston 55
Beijing 50
Venice 49
The Dalles 48
Frankfurt am Main 45
Parma 44
Cagliari 42
Seattle 42
Taranto 42
Hyderabad 41
Bergamo 39
Ottawa 39
Perugia 39
Princeton 39
Brussels 38
Messina 38
Lancaster 37
Mountain View 36
Cattolica 34
Pescara 34
Salerno 34
São Paulo 33
Fairfield 32
Reggio Emilia 32
Hefei 29
Livorno 29
Redmond 29
Kadoma 28
Trieste 27
Falls Church 26
Kunming 26
Hong Kong 25
Modena 25
Tianjin 25
Helsinki 24
Lucca 24
Novara 24
Seoul 24
Monza 23
Rimini 23
Abidjan 22
Izmir 22
Hebei 21
Jiaxing 20
Shenyang 20
Toronto 20
University Park 20
Augusta 19
Boardman 19
Düsseldorf 19
Paris 19
Caserta 18
Enterprise 18
Lauterbourg 18
London 18
Guangzhou 16
Macerata 16
Norwalk 16
Bolzano 15
Changsha 15
Chicago 15
Hangzhou 15
Leawood 15
Totale 9.864
Salva come PNG Salva come JPEG
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 10.038
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.119
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 854
Il ruolo della chemioimmunoterapia endovescicale nella neoplasia della vescica non muscolo invasiva “ non responder” 492
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 367
High intensity focused ultrasound (HIFU) in prostate cancer: today’s outcomes and tomorrow’s perspectives 310
Efficacia di un programma supervisionato perioperatorio di fisioterapia del pavimento pelvico per il miglioramento del recupero della continenza dopo prostatectomia radicale: trial randomizzato controllato 273
Studio trasversale sui sintomi e sulle complicanze del basso apparato urinario e sul loro impatto sulla qualità  della vita connessa alla salute (HRQL) in una coorte di pazienti con sclerosi multipla (MS) utilizzando questionari standardizzati 266
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 265
Efficacy of a supervised low-intensity regimen of perioperative pelvic floor muscle training in reducing postprostatectomy urinary incontinence: A randomized controlled trial 206
(99m)Tc-MAG3 diuretic renography in diagnosis of obstructive nephropathy in adults: a comparison between F-15 and a new procedure F+10(sp) in seated position 189
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 182
SEXUAL DYSFUNCTIONS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS: EVALUATION IN A CONTEMPORARY COHORT FROM A REFERRAL CENTER 177
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 155
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 144
The occult urothelial cancer 141
Complications of Extracorporeal Shock Wave Lithotripsy for Urinary Stones: To Know and to Manage Them–A Review 140
Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence 138
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 134
Male infertility: non-surgical therapy 134
Haemodynamic changes detected during open prostatectomy and transurethral resection for benign prostatic hyperplasia 133
Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial 131
Endourethral migration of a Hem-o-Lok Clip after robot-assisted laparoscopic radical prostatectomy 130
[Overactive bladder syndrome: the social and economic perspective] 127
Imaging in prostate cancer diagnosis: present role and future perspectives 126
Meccanismo d'azione del bioconiugato idrosolubile paclitaxel-acido ialuronico su linee cellulari umane di tumore della vescica 124
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 124
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 123
Hifu as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 123
Hot topics in urological health economics. A mini review 121
Antibiotic prophylaxis in urology 121
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 120
Bladder and prostate metastasis from small cell lung cancer: a rare entity 119
Advanced bladder cancer: New agents and new approaches. A review 118
Imaging in prostate cancer staging: present role e future perspectives 116
NBI: results review 115
Acid-base and electrolyte balance in urinary intestinal orthotopic reservoir: ileocecal neobladder compared with ileal neobladder 114
Imaging of renal cell carcinoma: state of the art and recent advances 114
Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up 114
HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3) 112
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 111
Size of Bladder Cancers: Correlation among Different Types of Measurement 110
Behavioural profile and human adaptation of survivors after radical cystectomy and ileal conduit 110
Advanced bladder cancer: New agents and new approaches. A review 108
Development of a questionnaire specifically for patients with Ileal Orthotopic Neobladder (IONB) 106
The Clinical Use of Statistical Permutation Test Methodology: A Tool for Identifying Predictive Variables of Outcome 106
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "bCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes 105
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 104
Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms 103
Bradeion (SEPT4) as a Urinary Marker of Transitional Cell Bladder Cancer: A Real-Time Polymerase Chain Reaction Study of Gene Expression 103
Imaging in prostate cancer staging: present role and future perspectives 101
Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives. 100
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 98
Therapeutic strategies in penile cancer: state of the art 98
[Innovative treatments of non muscle invasive bladder cancer] 98
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 98
The occult urothelial cancer 98
Is microsurgical technique really necessary in inguinal or sub-inguinal surgical treatment of varicocele? 97
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 97
Mitomycin C: new strategies to improve efficacy of a well-known therapy 97
Second-line intravesical therapy. What is the present role of device-assisted therapy? 96
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 93
Circumcision: history, religion and law 92
Imaging of renal cell carcinoma: state of the art and recent advances 92
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 91
Long-term behaviour of secretory immunity in ileocecal and ileal orthotopic neobladders. 90
Is extracorporeal shock wave lithotripsy in pediatrics a safe procedure? 90
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study. 88
Postoperative nomogram for invasive bladder cancer: Does it really work? A multicenter cohort study 87
Imaging in prostate cancer diagnosis: present role and future perspectives 87
Vitamin B12 and folic acid plasma levels after ileocecal and ileal neobladder reconstruction 86
Therapy for non-muscle invasive bladder cancer: HP-NAP 86
Postoperative nomogram for invasive bladder cancer: does it really work? A multicenter cohort study 84
Titanised Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-Out Single-Incision Technique: Minimum 12-Months Follow-Up Study 84
Postoperative nomogram for invasive bladder cancer: does it really work? A multicenter cohort study 82
Intensive intravesical mitomycin C therapy in non-muscle-invasive bladder cancer: a dose intensity approach. 78
Meccanismo d'azione del bioconiugato idrosolubile paclitaxel-acido ialuronico su linee cellulari umane di tumore della vescica 77
The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients 77
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression 77
Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study 74
Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens 71
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 71
Quality of life following urinary diversion: Orthotopic ileal neobladder versus ileal conduit. A multicentre study among long-term, female bladder cancer survivors 71
Improved non-invasive diagnosis of bladder cancer with an electronic nose: A large pilot study 71
Imaging of renal cell carcinoma: state of the art and recent advances. 70
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 69
Metanephric adenoma with BRAF V600K mutation and a doubtful radiological imaging: pitfalls in the diagnostic process 67
Quality of Life Assessment With Orthotopic Ileal Neobladder Reconstruction After Radical Cystectomy: Results From a Prospective Italian Multicenter Observational Study 65
Patient pad count is a poor measure of urinary incontinence compared with 48-h pad test: results of a large-scale multicentre study 65
Systematic review and meta-analysis of non RCT's on health related quality of life after radical cystectomy using validated questionnaires: Better results with orthotopic neobladder versus ileal conduit 63
Intraprostatic botulinum toxin type "A" injection in patients with benign prostatic hyperplasia and unsatisfactory response to medical therapy: A randomized, double-blind, controlled trial using urodynamic evaluation 62
Second-Line Conservative Device-Assisted Intravesical Treatment in Selected Patients With Recurrent High-Risk Non–Muscle-Invasive Bladder Cancer 62
Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer? 61
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 59
Health-Related Quality of Life after Radical Cystectomy for Bladder Cancer in Elderly Patients with Ileal Orthotopic Neobladder or Ileal Conduit: Results from a Multicentre Cross-Sectional Study Using Validated Questionnaires 59
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 58
Immediate ileal ureter replacement for ureteral avulsion during ureterescopy 57
Implementation of frailty preoperative assessment to predict outcome in patients undergoing urological surgery: a systematic review and meta-analysis 53
The cost of treatment and follow-up of bladder cancer in Italy 51
[Androgen-deprivation therapy in prostate cancer: clinical evidence and future perspectives] 51
Totale 23.164
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.141
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.141
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020316 0 0 0 0 0 0 0 0 0 0 187 129
2020/20211.191 46 118 51 111 161 69 134 43 146 66 181 65
2021/20221.385 136 86 45 104 110 77 56 174 94 81 189 233
2022/20234.082 416 397 268 493 215 396 196 338 441 213 400 309
2023/20245.933 330 583 373 514 407 456 453 575 426 565 559 692
2024/20257.694 580 690 746 629 798 608 619 647 946 653 778 0
Totale 24.437